150 related articles for article (PubMed ID: 17903220)
1. Altered CD45 isoform expression in C77G carriers influences cytokine responsiveness and adhesion properties of T cells.
Windhagen A; Sönmez D; Hornig-Do HT; Kalinowsky A; Schwinzer R
Clin Exp Immunol; 2007 Dec; 150(3):509-17. PubMed ID: 17903220
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of CD45RA isoforms in carriers of the C77G mutation leads to hyporeactivity of CD4+CD25highFoxp3+ regulatory T cells.
Pokoyski C; Lienen T; Rother S; Schock E; Plege-Fleck A; Geffers R; Schwinzer R
Genes Immun; 2015 Dec; 16(8):519-27. PubMed ID: 26355564
[TBL] [Abstract][Full Text] [Related]
3. The 77C->G mutation in the human CD45 (PTPRC) gene leads to increased intensity of TCR signaling in T cell lines from healthy individuals and patients with multiple sclerosis.
Do HT; Baars W; Borns K; Windhagen A; Schwinzer R
J Immunol; 2006 Jan; 176(2):931-8. PubMed ID: 16393978
[TBL] [Abstract][Full Text] [Related]
4. [Prevalence of C77G polymorphism in exon 4 of the CD45 gene in the Spanish population].
Gil J; Ruiz-Tíscar JL; Rodríguez-Sainz C; Hernández A; Santamaría B; García-Sánchez F; Fernández-Cruz E
Med Clin (Barc); 2005 Jun; 125(1):10-1. PubMed ID: 15960938
[TBL] [Abstract][Full Text] [Related]
5. Altered CD45 expression in C77G carriers influences immune function and outcome of hepatitis C infection.
Dawes R; Hennig B; Irving W; Petrova S; Boxall S; Ward V; Wallace D; Macallan DC; Thursz M; Hill A; Bodmer W; Beverley PC; Tchilian EZ
J Med Genet; 2006 Aug; 43(8):678-84. PubMed ID: 16505159
[TBL] [Abstract][Full Text] [Related]
6. Disease associations and altered immune function in CD45 138G variant carriers.
Boxall S; Stanton T; Hirai K; Ward V; Yasui T; Tahara H; Tamori A; Nishiguchi S; Shiomi S; Ishiko O; Inaba M; Nishizawa Y; Dawes R; Bodmer W; Beverley PC; Tchilian EZ
Hum Mol Genet; 2004 Oct; 13(20):2377-84. PubMed ID: 15333587
[TBL] [Abstract][Full Text] [Related]
7. Combinations of CD45 isoforms are crucial for immune function and disease.
Dawes R; Petrova S; Liu Z; Wraith D; Beverley PC; Tchilian EZ
J Immunol; 2006 Mar; 176(6):3417-25. PubMed ID: 16517710
[TBL] [Abstract][Full Text] [Related]
8. A CD45 polymorphism associated with abnormal splicing is absent in African populations.
Tchilian EZ; Dawes R; Ramaley PA; Whitworth JA; Yuldasheva N; Wells RS; Watera C; French N; Gilks CF; Kunachiwa W; Ruzibakiev R; Leetrakool N; Carrington CV; Ramdath DD; Gotch F; Stephens HA; Hill AV; Beverley PC
Immunogenetics; 2002 Feb; 53(10-11):980-3. PubMed ID: 11862398
[TBL] [Abstract][Full Text] [Related]
9. CD45 and multiple sclerosis: the exon 4 C77G polymorphism (additional studies and meta-analysis) and new markers.
Gomez-Lira M; Liguori M; Magnani C; Bonamini D; Salviati A; Leone M; Andreoli V; Trojano M; Valentino P; Savettieri G; Quattrone A; Pignatti PF; Momigliano-Richiardi P; Giordano M
J Neuroimmunol; 2003 Jul; 140(1-2):216-21. PubMed ID: 12864992
[TBL] [Abstract][Full Text] [Related]
10. Abnormal cell surface antigen expression in individuals with variant CD45 splicing and histiocytosis.
Boxall S; McCormick J; Beverley P; Strobel S; De Filippi P; Dawes R; Klersy C; Clementi R; De Juli E; Ferster A; Wallace D; Aricò M; Danesino C; Tchilian E
Pediatr Res; 2004 Mar; 55(3):478-84. PubMed ID: 14630980
[TBL] [Abstract][Full Text] [Related]
11. The exon A (C77G) mutation is a common cause of abnormal CD45 splicing in humans.
Tchilian EZ; Wallace DL; Imami N; Liao HX; Burton C; Gotch F; Martinson J; Haynes BF; Beverley PC
J Immunol; 2001 May; 166(10):6144-8. PubMed ID: 11342634
[TBL] [Abstract][Full Text] [Related]
12. A C77G point mutation in CD45 exon 4, which is associated with the development of multiple sclerosis and increased susceptibility to HIV-1 infection, is undetectable in Japanese population.
Sabouri AH; Saito M; Matsumoto W; Kodama D; Farid R; Izumo S; Usuku K; Osame M
Eur J Neurol; 2003 Nov; 10(6):737-9. PubMed ID: 14641523
[TBL] [Abstract][Full Text] [Related]
13. No association between systemic sclerosis and C77G polymorphism in the human PTPRC (CD45) gene.
Kirsten H; Blume M; Emmrich F; Hunzelmann N; Mierau R; Rzepka R; Vaith P; Witte T; Melchers I; Ahnert P
J Rheumatol; 2008 Sep; 35(9):1817-9. PubMed ID: 18634151
[TBL] [Abstract][Full Text] [Related]
14. An investigation of the C77G and C772T variations within the human protein tyrosine phosphatase receptor type C gene for association with multiple sclerosis in an Australian population.
Szvetko AL; Jones A; Mackenzie J; Tajouri L; Csurhes PA; Greer JM; Pender MP; Griffiths LR
Brain Res; 2009 Feb; 1255():148-52. PubMed ID: 19111528
[TBL] [Abstract][Full Text] [Related]
15. A novel mutation in PTPRC interferes with splicing and alters the structure of the human CD45 molecule.
Jacobsen M; Hoffmann S; Cepok S; Stei S; Ziegler A; Sommer N; Hemmer B
Immunogenetics; 2002 Jun; 54(3):158-63. PubMed ID: 12073144
[TBL] [Abstract][Full Text] [Related]
16. Outcome of children treated with haematopoietic-stem cell transplantations from donors expressing the rare C77G variant of the PTPRC (CD45) gene.
Samaan S; Guérin-El Khourouj V; Auboeuf D; Peltier L; Pédron B; Ouachée-Chardin M; Gourgouillon N; Baruchel A; Dalle JH; Sterkers G
Br J Haematol; 2011 Apr; 153(1):47-57. PubMed ID: 21323873
[TBL] [Abstract][Full Text] [Related]
17. Dual expression of CD45RA and CD45RO isoforms on myelin basic protein-specific CD4+ T-cell lines in multiple sclerosis.
Qin Y; Van Den Noort S; Kurt J; Gupta S
J Clin Immunol; 1993 Mar; 13(2):152-61. PubMed ID: 7686563
[TBL] [Abstract][Full Text] [Related]
18. CD45 isoform expression in autoimmune myasthenia gravis.
Tackenberg B; Nitschke M; Willcox N; Ziegler A; Nessler S; Schumm F; Oertel WH; Hemmer B; Sommer N
Autoimmunity; 2003 Mar; 36(2):117-21. PubMed ID: 12820694
[TBL] [Abstract][Full Text] [Related]
19. Unusual case presentations associated with the CD45 C77G polymorphism.
Tchilian EZ; Gil J; Navarro ML; Fernandez-Cruz E; Chapel H; Misbah S; Ferry B; Renz H; Schwinzer R; Beverley PC
Clin Exp Immunol; 2006 Dec; 146(3):448-54. PubMed ID: 17100764
[TBL] [Abstract][Full Text] [Related]
20. C77G in PTPRC (CD45) is no risk allele for ovarian cancer, but associated with less aggressive disease.
Landskron J; Kraggerud SM; Wik E; Dørum A; Bjørnslett M; Melum E; Helland Ø; Bjørge L; Lothe RA; Salvesen HB; Taskén K
PLoS One; 2017; 12(7):e0182030. PubMed ID: 28759630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
